Protective Effect of Verapamil on Gastric Hemorrhagic Ulcers in Severe Atherosclerotic Rats

Chen-Road Hung

gastric hemorrhagic ulcer ； histamine ； acid back-diffusion ； microvascular permeability ； verapamil

The Chinese Journal of Physiology

50卷6期（2007 / 12 / 01）

315 - 325

英文

Studies concerning with pathogenesis of gastric hemorrhage and mucosal ulceration produced in atherosclerotic rats are lacking. The aim of this study is to examine the role of gastric acid backdiffusion, mast cell histamine release, lipid peroxide (LPO) generation and mucosal microvascular permeability in modulating gastric hemorrhage and ulcer in rats with atherosclerosis induced by coadministration of vitamin D2 and cholesterol. Additionally, the protective effect of verapamil on this ulcer model was evaluated. Male Wistar rats were challenged intragastrically once daily for 9 days with 1.0ml/kg of corn oil containing vitamin D2 and cholesterol to induce atherosclerosis. Control rats received corn oil only. After gastric surgery, rat stomachs were irrigated for 3h with either simulated gastric juice or normal saline. Gastric acid back-diffusion, mucosal LPO generation, histamine concentration, microvascular permeability, luminal hemoglobin content and ulcer areas were determined. Elevated atherosclerotic parameters, such as serum calcium, total cholesterol and low-density lipoprotein concentration were obtained in atherosclerotic rats. Severe gastric ulcers accompanied with increased ulcerogenic factors, including gastric acid back-diffusion, histamine release, LPO generation and luminal hemoglobin content were also observed in these rats. Moreover, a positive correlation of histamine to gastric hemorrhage and to ulcer was found in those atherosclerotic rats. This hemorrhagic ulcer and various ulcerogenic parameters were dose-dependently ameliorated by daily intragastric verapamil. Atherosclerosis could produce gastric hemorrhagic ulcer via aggravation of gastric acid back-diffusion, LPO generation, histamine release and microvascular permeability that could be ameliorated by verapamil in rats.

1. Alican, I.,Toker, F.,Arbak, S.,Yegen, B.C.,Yalcin, A.S.,Oktay, S.(1994).Gastric lipid peroxidation, glutathione and calcium channel blockers in the stress-induced ulcer model in rats.Pharmacol. Res.,30,123-135.
2. Andersson, K.,Mattsson, H.,Larsson, H.(1990).The role of gastric mucosal histamine in acid secretion and experimentally induced lesions in the rat.Digestion,46,1-9.
3. Barman,S.A.,Olson, M.D.,Saari, J.T.(1987).Histamine induced alteration of calcium bindng to microvascular endothelium as indicated by use of ionic lanthanum.Cardiovasc. Res,21,576-581.
4. Bennani-Kabchi, N.,Kehel, L.,el Bouayadi, F.,Fdhil, H.,Amarti, A.,Saidi, A.,Marquie, G.(1999).New model of atherosclerosis in sand rats subjected to a high cholesterol diet and vitamin D2..Therapie,54,559-565.
5. Cho, C.H.,Luk, C.T.,Ogle, C.W.(1991).The membrane-stabilizing action of zinc carnosine (Z-103) in stress-induced gastric ulceration in rats.Life Sci.,49,189-194.
6. Davenport, H.W.,Chavre V.J.(1968).Destruction of the gastric mucosal barrier by detergents and urea.Gastroenterology,54,175-181.
7. Den Tandt, W.R.,van Hoof, F.(1989).Niemann-Pick disease type C could result from a genetic deficiency of cholesterol egress from the lysosomes.J. Inherit. Metab. Dis.,12,483-484.
8. Di Bello, M.G.,Masini, E.,Ioannides, C.,Fomusi Ndisang, J.,Raspanti, S.,Bani Sacchi, T.,Mannaioni, P.F.(1998).Histamine release from rat mast cells induced by the metabolic activation of drugs of abuse into free radicals.Inflam. Res.,47,122-130.
9. Gislason, H.,Sorbye, H.,Abdi-Dezfuli, F.,Waldum, H.L.,Svanes K.(1995).Role of prostaglandins and histamine in hyperemic response to superficial and deep gastric mucosal injury and H+ backdiffusion in cats.Dig. Dis. Sci.,40,1669-1678.
10. Grega, G.J.,Adamski, S.W.(1991).Differential effects of inhibitors of cellular function on inflammatory mediator-stimulated increases in vascular permeability.Microcirc. Endoth. Lymph.,7,217-244.
11. Guler, C.,Samli, M.,Aksoy, Y.,Demirbas, M.,Kilinc, A.,Ellidokuz, E.,Dincel, C.(2004).Effects of carbon dioxide pneumoretroperitoneum on free radical formation in remote organs and use of verapamil as an antioxidant.J. Endourol,18,245-249.
12. Gutierrez-Cabano, C.A.(1993).Prostaglandins and sulfhydryls may mediate gastric protection induced by verapamil in rats.Dig. Dis. Sci.,38,2043-2048.
13. Hernandez, R.H.,Armas-Hernandez, M.J.,Velasco, M.,Israili, Z.H.,Armas-Padilla, M.C.(2003).Calcium antagonists and atherosclerosis protection in hypertension.Am. J. Art. Ther,10,409-414.
14. Holzer, P.,Pabst, M.A.,Lippe, I.T.(1989).Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa.Gastroenterology,96,1425-1433.
15. Horowitz, B.Z.,Marquardt, K.,Swenson, E.(1997).Calcium polysulfide overdose: a report of two cases.J. Toxicol. Clin. Toxicol.,35,299-303.
16. Hudson, N.,Murray, F.E.,Cole, A.T.,Turnbull, G.M.,Lettis, S.,Hawkey, C.(1994).Ranitidine, bismuth citrate and aspirin-induced gastric mucosal injury. Aliment.Pharmacol. Ther.,7,515-521.
17. Hung, C.R.(2001).Role of histamine in aggravation of gastric acid backdiffusion and vascular permeability in septic rats..Chinese J. Physiol,44,199-206.
18. Hung, C.R.(2000).Importance of histamine, glutathione and oxyradicals in modulating gastric hemorrhagic ulcer in septic rats.Clin. Exp. Pharmacol. Physiol.,27,306-312.
19. Hung, C.R.,Huang, E.Y.(1995).Role of acid back-diffusion in the formation of mucosal ulceration and its treatment with drugs in diabetic rats.J. Pharm. Pharmacol.,47,493-498.
20. Hung, C.R.,Neu, S.L.(1997).Acid-induced gastric damage in rats is aggravated by starvation and prevented by several nutrients.J. Nutr,127,630-636.
21. Karevina, T.G.(1990).Effect of H(subscript 1)- and H(subscript 2) -histamine receptor blockades on lesions of gastric mucosa evoked by exogenous histamine in guinea pigs.Patol. Fiziol. Eksp. Ter.,5,43-45.
22. Karmansky, I.,Gruener, N.(1997).A mechanism of antioxidant activity of calcium antagonist verapamil against LDL oxidation.Clin. Chim. Acta.,259,177-182.
23. Kedziora-Kornatowska, K.,Szram,S.,Kornatowski, T.,Szadujkis-Szadurski, L.,Kedziora, J.,Bartosz, G.(2002).The effect of verapamil on the antioxidant defense system in diabetic kidney.Clin. Chim. Acta.,322,105-112.
24. Kunitomo, M.,Kinoshita, K.,Bando, Y.(1981).Experimental atherosclerosis in rats treated a vitamin D, cholesterol-rich diet.J. Pharmacobiodyn.,4,718-723.
25. Mak, I.T.,Boehme, P.,Weglicki, W.B.(1995).Protective effects of calcium channel blockers against free radical-impaired endothelial cell proliferation.Biochem. Pharmacol.,150,1531-1534.
26. Malloy, M.J.,Kane, J.P.,Katzung, B.G. (Edit)(2004).Agents used in hyperlipidemia. In: Basic & Clinical Pharmacology..New York:Lange Mc Graw Hill.
27. Malo, P.E.,Wasserman, M.A.(1986).The effect of calcium antagonists on histamine and leukotriene-induced tracheal microvascular permeability in the guinea pig.Prostaglandins,32,221-233.
28. Montgomery, D.C.(1984).Experiments to compare several treatments: The analysis of variance. In: Design and analysis of experiments.New York:John, Wiley.
29. Negre-Salvayre, A.,Salvayre, R.(1992).Protection by Ca(superscript 2+) channel blockers (nifedipine, diltiazem and verapamil ) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.Br. J. Pharmacol.,107,738-744.
30. Ohkawa, H.,Ohishi, N.,Yagi, K.(1979).Assay for lipid peroxide in animal tissues by thiobarbituric acid reaction.Anal. Biochem.,95,351-358.
31. Redinger, R.N.(2003).Nuclear receptors in cholesterol catabolism: molecular biology of the enterohepatic circulation of bile salts and its role in cholesterol homeostasis.J. Lab. Clin. Med.,142,7-20.
32. Rojstaczer, N.,riggle, D.J.(1996).Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.Biochem. Pharmacol.,51,141-150.
33. Ronnberg ,A.L.,Hakanson, R.(1984).A simplified procedure for the fluometric determination of histamine in rat stomach.Agen. Act,14,195-199.
34. Stein, H.J.,Oosthuizen, M.M.,Hinder, R.A.,Lamprechts. H.(1993).Effect of verapamil on hepatic ischemia/reperfusion injury.Am. J. Surg,165,96-100.
35. Steiner, R.D.,Linck, L.M.,Flavell, D.P.,Lin, D.S.,Connor, W.E.(2000).Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production..J. Lipid Res.,41,1437-1447.
36. Stocker, R.,Keaney, J.F.(2004).Role of oxidative modifications in atherosclerosis.Physiol. Rev,84,1381-1478.
37. Sugawara, H.,Tobise, K.,Kikuchi, K.(1996).Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.Hypertens. Res.,19,223-228.
38. Takeuchi, K.,Furukawa, O.,Nishiwaki, H.,Okabe S.(1987).16, 16-dimethyl prostaglandin E2 aggravates gastric mucosal injury induced by histamine in rats—Possible role of the increased mucosal vascular permeability..Gastroenterology,93,1276-1286.
39. Tarnawski, A.,Hollander, D.,Gergely, H.,Stachura, J.(1985).Comparision of antacid, sucralfate, cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury..Am. J. Med,79,19-23.
40. Tulenko, T.N.,Laury-Kleintop, L.,Walter, M.F.,Mason, R.P.(1997).Cholesterol, calcium and atherosclerosis: is there a role for calcium channel blockers in atheroprotection?.Int. J. Cardiol.,62,55-66.
41. Yokoyama, M.(2004).Oxidant stress and atherosclerosis.Curr. Opin. Pharmacol,4,110-115.